Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > AusBiotech supports 'Raising the Bar'

Abstract:
AusBiotech welcomes a legislative Bill that has been introduced into the
Australian Parliament today - The Intellectual Property Laws Amendment
(Raising the Bar) Bill 2011.

AusBiotech supports 'Raising the Bar'

Australia | Posted on June 21st, 2011

AusBiotech confirms its support in general for this package of
intellectual property reform developed by IP Australia and contained in
the 'Raising the Bar' Bill. Specifically, AusBiotech is in favour of a
broad research use exemption from patent infringement becoming enshrined
in Australia's patent law so this country's researchers and industry may
be confident as they strive to innovate.

In its recent submission to the Senate Inquiry into the Patent Amendment
(Human Genes & Biological Materials) Bill 2010, AusBiotech stated its
belief that the thresholds for patentability should be properly set and
rigorously applied across all forms of invention, ie: in a
technology-neutral manner. AusBiotech has publicly and strongly opposed
the Patent Amendment (Human Genes & Biological Materials) Bill 2010, as
it completely fails to address any of the community's valid concerns and
threatens scientific research and development on biological materials.

AusBiotech is instead in favour of the Government's 'Raising the Bar'
Bill which, when taken together with the erudite recommendations from
the Australian Law Reform Commission 1999 report, the Senate Inquiry
into Gene Patents (2010) and the Advisory Council on Intellectual
Property 2010 review will deliver the solutions to address the issues
identified by clinicians, researchers, industry and the community.

AusBiotech strongly encourages the Australian Parliament to support the
Bill so that the many consequential benefits of the law reform can be
effected.

Dr Anna Lavelle, CEO of AusBiotech said: "Two years of consultation and
deliberation that has resulted in the "Raising the Bar' Bill, will
guarantee a strengthening of Australia's IP management system."

####

About AusBiotech
AusBiotech is Australia's voice on biotechnology, and represents more
than 3,000 members, encompassing medicines, medical diagnostics and
devices, agriculture, alternative fuels and climate change.

For more information, please click here

Contacts:
Lorraine Chiroiu
AusBiotech
Communications Manager
03 9828 1414 / 0429 801118

Copyright © AusBiotech

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Govt.-Legislation/Regulation/Funding/Policy

Giving batteries a longer life with the Advanced Photon Source: New research uncovers a hydrogen-centered mechanism that triggers degradation in the lithium-ion batteries that power electric vehicles September 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Single atoms show their true color July 5th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project